日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

COVID-19 疫苗 BNT162b1 可引发人类抗体和 TH1 T 细胞反应

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, Isabel Vogler, Lena M Kranz, Mathias Vormehr, Alina Baum, Kristen Pascal, Jasmin Quandt, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Julian Sikorski, Rolf Hilker, Dirk Becker, Ann-Kathrin Eller, Jan Grützner, Carsten Boesler, Corinna Rosen

An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation

Fc 惰性 PD-L1×4-1BB 双特异性抗体通过结合检查点抑制和条件性 4-1BB 共刺激在小鼠中介导强大的抗肿瘤免疫

Alexander Muik, Isil Altintas, Friederike Gieseke, Kristina B Schoedel, Saskia M Burm, Aras Toker, Theodora W Salcedo, Dennis Verzijl, David Eisel, Christian Grunwitz, Lena M Kranz, Mathias Vormehr, David P E Satijn, Mustafa Diken, Sebastian Kreiter, Kate Sasser, Tahamtan Ahmadi, Özlem Türeci, Esthe

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

地塞米松预防用药可抑制疫苗诱导的抗癌免疫反应

Mathias Vormehr, Sophie Lehar, Lena M Kranz, Siri Tahtinen, Yoko Oei, Vincent Javinal, Lélia Delamarre, Kerstin C Walzer, Mustafa Diken, Sebastian Kreiter, Ira Mellman, Ugur Sahin, Jill M Schartner, Özlem Türeci

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice

可移植肿瘤模型可用于研究 HLA-DRB1*0401 转基因小鼠中的 NY-BR-1 特异性 T 细胞反应

Krishna Das, David Eisel, Mathias Vormehr, Karin Müller-Decker, Adriane Hommertgen, Dirk Jäger, Inka Zörnig, Markus Feuerer, Annette Kopp-Schneider, Wolfram Osen, Stefan B Eichmüller

Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response

静脉注射 Toll 样受体 7 激动剂 SC1 可诱导 CD8+ T 细胞反应,从而控制肿瘤

Fulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, Mathias Vormehr, Magdalena Brkic, Stefan Strobl, Roman Rösemann, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Ugur Sahin

A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo

体内肿瘤衍生抗原暴露诱发的非功能性新表位特异性 CD8+ T 细胞反应

Mathias Vormehr, Katharina Reinhard, Renata Blatnik, Kathrin Josef, Jan David Beck, Nadja Salomon, Martin Suchan, Abderraouf Selmi, Fulvia Vascotto, Johannes Zerweck, Holger Wenschuh, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Angelika B Riemer, Ugur Sahin

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

系统性 RNA 递送至树突状细胞,利用抗病毒防御进行癌症免疫治疗

Lena M Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai, Kerstin C Reuter, Martin Meng, Daniel Fritz, Fulvia Vascotto, Hossam Hefesha, Christian Grunwitz, Mathias Vormehr, Yves Hüsemann, Abderraouf Selmi, Andreas N Kuhn, Janina Buck, Evelyna Derhovanessian, Richard Rae, Sebastia

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

突变的 MHC II 类表位可驱动癌症治疗性免疫反应

Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer, Mustafa Diken, Martin Löwer, Jan Diekmann, Sebastian Boegel, Barbara Schrörs, Fulvia Vascotto, John C Castle, Arbel D Tadmor, Stephen P Schoenberger, Christoph Huber, Özlem Türeci, Ugur Sahin